Jeremy Bender - Dec 31, 2022 Form 5 Insider Report for Day One Biopharmaceuticals, Inc. (DAWN)

Role
Chief Executive Officer, Director
Signature
/s/ Charles N. York II, Attorney-in-Fact
Stock symbol
DAWN
Transactions as of
Dec 31, 2022
Transactions value $
$0
Form type
5
Date filed
2/13/2023, 05:20 PM
Previous filing
Dec 22, 2022
Next filing
Jan 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DAWN Common Stock Gift $0 -282K -19.1% $0.00 1.19M Mar 31, 2022 Direct F1
transaction DAWN Common Stock Gift $0 +282K $0.00 282K Mar 31, 2022 See Footnote F1, F2
transaction DAWN Common Stock Gift $0 -282K -19.1% $0.00 1.19M Mar 31, 2022 Direct F1
transaction DAWN Common Stock Gift $0 +282K $0.00 282K Mar 31, 2022 See Footnote F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of the Issuer's Common Stock that the Reporting Person transferred as a bona fide gift for no consideration.
F2 Represents shares held by The Jeremy Bender 2022 Grantor Retained Annuity Trust under Irrevocable Trust Agreement dated March 29, 2022 of which the Reporting Person is trustee.
F3 Represents shares held by The Melissa Bender 2022 Grantor Retained Annuity Trust under Irrevocable Trust Agreement dated March 29, 2022 of which the Reporting Person's spouse is trustee.